Renagel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Sevelamer Hydrochloride.
| Product ID | 58468-0020_62a626e6-c535-4eb5-af9e-4dd5baac8e6a |
| NDC | 58468-0020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Renagel |
| Generic Name | Renagel |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-06-06 |
| Marketing End Date | 2020-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021179 |
| Labeler Name | Genzyme Corporation |
| Substance Name | SEVELAMER HYDROCHLORIDE |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2008-06-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021179 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-06-06 |
| Marketing End Date | 2020-03-01 |
| Ingredient | Strength |
|---|---|
| SEVELAMER HYDROCHLORIDE | 400 mg/1 |
| SPL SET ID: | 5e30120b-f2bf-43a0-86b2-44ae996dc681 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 17856-0021 | Renagel | Renagel |
| 53808-0777 | Renagel | Renagel |
| 58468-0020 | Renagel | Renagel |
| 58468-0021 | Renagel | sevelamer hydrochloride |
| 67544-656 | Renagel | Renagel |
| 68151-4295 | RENAGEL | Renagel |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RENAGEL 74590044 1978935 Live/Registered |
GENZYME CORPORATION 1994-10-24 |